Researchers in gastroenterology and hepatology at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), have ...

Russia's Gamaleya Center is set to commence human trials for a groundbreaking personalized mRNA melanoma vaccine, potentially revolutionizing cancer treatment.

Japan has launched clinical trials for a synthetic, universally compatible blood substitute, marking a potential breakthrough ...

SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of ...

Neuralink launched the first European clinical trial in the UK to test brain implants that let paralyzed patients control ...

Shilpa Medicare Serves as Lead Investor, Positioning Alveolus Bio for Phase 2 Clinical Trials and First-in-Human Studies ...

Pre-clinical trials of the Cancer Vaccine showed promising results in halting tumor growth and spread. The human trials will ...

Russia's Gamaleya Center, famed for Sputnik V, will initiate human trials for a personalized mRNA melanoma vaccine by late 2025. This innovative vaccine, tailored to individual tumor genetics using AI ...

Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind’s AlphaFold breakthrough, the company is ...

Moderna, the first to start human testing of a COVID vaccine, began a phase 1 safety study of its candidate vaccine in a small group of healthy adults on March 16, 2020. Results from that study ...

The Risks Of Using AI In Clinical Trials AI can streamline clinical trials, but it’s not without risks. AI should be used as an assistive tool for clinical trials, not a replacement for human ...

95% of clinical trials fail because animal testing is no substitute for human biology - Vivodyne’s robotics platform grows thousands of human tissues daily, directly tackling the biological gap ...